Bertrand Tombal

The PCa models will be put offline on January 8th, 2019.
Interested in uro-oncology? Check out our new accredited PinPoint case platform on

Bertrand Tombal

University Hospital Saint-Luc, Urology

Professor Bertrand Tombal is Chairman of the Division of Urology and Professor of Urology at the Université catholique de Louvain (UCL), Cliniques universitaires Saint-Luc, Brussels, Belgium. He is member of the Belgian Royal Academy of Medicine.

He is the President of the Board of European Organization for Research and Treatment in Cancer (EORTC), the leading European academic research organization in the field of cancer, where he acts as chairman of the Clinical Trial Division and of the Genitourinary Cancer Group.

He has both a basic science and a clinical interest in urological oncology, particularly in the field of prostate and bladder cancer. Professor Tombal obtained his MD in 1990 and his PhD in 2003, both from the Université catholique de Louvain. During his PhD, he studied the mechanisms involved in apoptosis of prostate cancer cells and the modulation of apoptosis by growth factors. He completed part of his basic sciences training at Johns Hopkins University, Baltimore, MD, USA.

Professor Tombal’s primary clinical interest is the treatment of advanced stages of prostate cancer, and particularly hormonal treatment and development of new biological agents. He is heading the uro-oncology division at the Université catholique de Louvain where he is coordinating several trials in this research area. In addition, Professor Tombal has authored many published papers, books, and book chapters. He has presented at numerous national and international conferences and has been the recipient of various awards for his research in the field of urology, including the European Association of Urology thesis award, which he received in 2003.

Professor Tombal is also member of Belgium College of Oncology, the Skeletal Care Academy, and member of the Scientific Office of European Association of Urology.